AVITA Medical, Inc. (RCEL) Q3 2022 Earnings Call Transcript

SA Transcripts profile picture
SA Transcripts

AVITA Medical, Inc. (NASDAQ:RCEL) Q3 2022 Earnings Conference Call November 10, 2022 4:30 PM ET

Company Participants

Caroline Corner - Managing Director, Investor Relations

Jim Corbett - Chief Executive Officer

Michael Holder - Chief Financial Officer

Conference Call Participants

Charlie Montang - Lake Street Capital

Matthew O’Brien - Piper Sandler

Ryan Zimmerman - BTIG

Joshua Jennings - Cowen

Madeleine Williams - Wilsons


Good day and thank you for standing by and welcome to AVITA Medical Third Quarter 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. After the speakers’ presentation, there’ll be a question-and-answer session. [Operator Instructions] Please be advised that today’s conference is being recorded.

I would now like to hand the conference over to your speaker today, Jim Corbett, CEO. Please go ahead.

Caroline Corner

Thank you, operator. Welcome to AVITA Medical third quarter 2022 earnings call. Joining me on today’s call are Jim Corbett, Chief Executive Officer; and Michael Holder, Chief Financial Officer.

This call will include forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements made on this call that do not relate to matters of historical facts should be considered forward-looking statements, including statements regarding the markets in which AVITA Medical operates, trends, demand and expectations for its products and technology, its expected financial performance, expenses and position in the market and the impact of COVID-19 on its operations and its customers’ operations.

These statements are neither promises nor guarantees and involve known and unknown risks and uncertainties that could cause actual results, performance or achievements that differ materially from any results, performance or achievements expressed or implied by the forward-looking statements.

Please review AVITA Medical’s most recent filings with the SEC, particularly the risk factors described in AVITA Medical’s S3 and 10-K

Recommended For You

Comments (2)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.